drugset / Trial / NCT07325253
A Pilot Study to Correlate 4-18F- Fluoro-1-naphthol 18F-4FN PET/CT Imaging With Chronic Graft Versus Host Disease Manifestations
Non-randomizedParallel-groupOpen-labelDiagnostic
Summary
To study the safety and possible side effects of using the imaging agent 4-\[18F\]Fluoro-1-Naphthol (also called \[18F\]4FN) in PET/CT scans for participants with chronic GVHD.
Timeline
- Start
- 2025-11-18
- Primary completion
- 2028-01-03
- Completion
- 2030-01-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 4-[18F]Fluoro-1-Naphthol | Diagnostic / imaging agent | — | Intravenous |